{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:54:47Z","timestamp":1792079687093,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health and the National Rosacea Society"}],"content-domain":{"domain":["clinicalkey.jp","jdsjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jdermsci.2018.12.004","type":"journal-article","created":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T11:54:14Z","timestamp":1545998054000},"page":"58-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Botulinum toxin blocks mast cells and prevents rosacea like inflammation"],"prefix":"10.1016","volume":"93","author":[{"given":"Jae Eun","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Werbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony L.","family":"Yaksh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Di Nardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"January (1)","key":"10.1016\/j.jdermsci.2018.12.004_bib0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jaad.2017.08.037","article-title":"Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea society Expert Committee","volume":"78","author":"Gallo","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"May (5)","key":"10.1016\/j.jdermsci.2018.12.004_bib0010","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","article-title":"Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors","volume":"72","author":"Two","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"May (3)","key":"10.1016\/j.jdermsci.2018.12.004_bib0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00281-018-0675-z","article-title":"Skin neurogenic inflammation","volume":"40","author":"Choi","year":"2018","journal-title":"Semin. Immunopathol."},{"issue":"April (4)","key":"10.1016\/j.jdermsci.2018.12.004_bib0020","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jid.2016.10.046","article-title":"TRPV4 mediates mast cell activation in cathelicidin-induced Rosacea inflammation","volume":"137","author":"Mascarenhas","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"August (8)","key":"10.1016\/j.jdermsci.2018.12.004_bib0025","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat. Med."},{"issue":"November (6862)","key":"10.1016\/j.jdermsci.2018.12.004_bib0030","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/35106587","article-title":"Innate antimicrobial peptide protects the skin from invasive bacterial infection","volume":"414","author":"Nizet","year":"2001","journal-title":"Nature"},{"issue":"June (11)","key":"10.1016\/j.jdermsci.2018.12.004_bib0035","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1172\/JCI17545","article-title":"An angiogenic role for the human peptide antibiotic LL-37\/hCAP-18","volume":"111","author":"Koczulla","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"April (4)","key":"10.1016\/j.jdermsci.2018.12.004_bib0040","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/jid.2008.320","article-title":"Collagen synthesis is suppressed in dermal fibroblasts by the human antimicrobial peptide LL-37","volume":"129","author":"Park","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"October (7)","key":"10.1016\/j.jdermsci.2018.12.004_bib0045","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.192.7.1069","article-title":"LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells","volume":"192","author":"Yang","year":"2000","journal-title":"J. Exp. Med."},{"issue":"May (5)","key":"10.1016\/j.jdermsci.2018.12.004_bib0050","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1523-1747.2003.12132.x","article-title":"Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18\/LL-37) prosequence","volume":"120","author":"Zaiou","year":"2003","journal-title":"J. Invest. Dermatol."},{"issue":"October (12)","key":"10.1016\/j.jdermsci.2018.12.004_bib0055","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1096\/fj.06-6075com","article-title":"Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin","volume":"20","author":"Yamasaki","year":"2006","journal-title":"FASEB J."},{"issue":"June (6)","key":"10.1016\/j.jdermsci.2018.12.004_bib0060","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaad.2016.01.023","article-title":"Improved clinical outcome and biomarkers in adults with papulopustular rosacea treated with doxycycline modified-release capsules in a randomized trial","volume":"74","author":"Di Nardo","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"issue":"November (11)","key":"10.1016\/j.jdermsci.2018.12.004_bib0065","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/jid.2014.222","article-title":"Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea","volume":"134","author":"Muto","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"August (4)","key":"10.1016\/j.jdermsci.2018.12.004_bib0070","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.4049\/jimmunol.0803587","article-title":"The cathelicidin LL-37 activates human mast cells and is degraded by mast cell tryptase: counter-regulation by CXCL4","volume":"183","author":"Schiemann","year":"2009","journal-title":"J. Immunol. (Baltimore, Md : 1950)"},{"issue":"Febuary (2)","key":"10.1016\/j.jdermsci.2018.12.004_bib0075","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1248\/bpb.31.212","article-title":"Human cathelicidin CAP18\/LL-37 changes mast cell function toward innate immunity","volume":"31","author":"Yoshioka","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"July","key":"10.1016\/j.jdermsci.2018.12.004_bib0080","article-title":"Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics","volume":"04","author":"Holmes","year":"2016","journal-title":"Exp. Dermatol."},{"issue":"May (5)","key":"10.1016\/j.jdermsci.2018.12.004_bib0085","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jaad.2014.08.027","article-title":"Rosacea: part II. Topical and systemic therapies in the treatment of rosacea","volume":"72","author":"Two","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"July (6)","key":"10.1016\/j.jdermsci.2018.12.004_bib0090","first-page":"348","article-title":"Burden of disease: the psychosocial impact of Rosacea on a patient\u2019s quality of life","volume":"6","author":"Huynh","year":"2013","journal-title":"Am. Health Drug Benefits"},{"issue":"September (3)","key":"10.1016\/j.jdermsci.2018.12.004_bib0095","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaad.2012.04.017","article-title":"Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonselective beta-adrenergic blocker","volume":"67","author":"Hsu","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"issue":"February (2)","key":"10.1016\/j.jdermsci.2018.12.004_bib0100","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/archdermatol.2011.2615","article-title":"Neurogenic rosacea treated with endoscopic thoracic sympathectomy","volume":"148","author":"Schram","year":"2012","journal-title":"Arch. Dermatol."},{"issue":"March (3)","key":"10.1016\/j.jdermsci.2018.12.004_bib0105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2133.1999.02744.x","article-title":"The response of erythematous rosacea to ondansetron","volume":"140","author":"Wollina","year":"1999","journal-title":"Br. J. Dermatol."},{"issue":"March (3)","key":"10.1016\/j.jdermsci.2018.12.004_bib0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/archderm.1983.01650270029012","article-title":"Effect of subdepressor clonidine on flushing reactions in rosacea. Change in malar thermal circulation index during provoked flushing reactions","volume":"119","author":"Wilkin","year":"1983","journal-title":"Arch. Dermatol."},{"issue":"July (1)","key":"10.1016\/j.jdermsci.2018.12.004_bib0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2133.1982.tb00290.x","article-title":"Alcohol-induced rosacea flushing blocked by naloxone","volume":"107","author":"Bernstein","year":"1982","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.jdermsci.2018.12.004_bib0120","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000368773","article-title":"Botulinum toxin for the treatment of refractory erythema and flushing of rosacea","volume":"230","author":"Park","year":"2015","journal-title":"Dermatology"},{"issue":"December (12)","key":"10.1016\/j.jdermsci.2018.12.004_bib0125","first-page":"e76","article-title":"A new treatment regimen for rosacea: onabotulinumtoxinA","volume":"11","author":"Dayan","year":"2012","journal-title":"J. Drugs Dermatol."},{"issue":"June (6)","key":"10.1016\/j.jdermsci.2018.12.004_bib0130","first-page":"549","article-title":"Pilot, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of IncobotulinumtoxinA Injections in the Treatment of Rosacea","volume":"16","author":"Dayan","year":"2017","journal-title":"J. Drugs Dermatol."},{"issue":"August (2 Pt.1)","key":"10.1016\/j.jdermsci.2018.12.004_bib0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1067\/mjd.2000.105567","article-title":"Pharmacology of botulinum toxin","volume":"43","author":"Huang","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"issue":"August (Pt. 16)","key":"10.1016\/j.jdermsci.2018.12.004_bib0140","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1242\/jcs.012211","article-title":"Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential","volume":"120","author":"Meng","year":"2007","journal-title":"J. Cell. Sci."},{"issue":"October (5)","key":"10.1016\/j.jdermsci.2018.12.004_bib0145","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","article-title":"Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A","volume":"26","author":"Aoki","year":"2005","journal-title":"Neurotoxicology"},{"issue":"March (Pt. 3)","key":"10.1016\/j.jdermsci.2018.12.004_bib0150","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1113\/jphysiol.2004.080952","article-title":"Mechanisms of acetylcholine-mediated vasodilatation in young and aged human skin","volume":"563","author":"Holowatz","year":"2005","journal-title":"J. Physiol. (Lond.)"},{"issue":"October (4)","key":"10.1016\/j.jdermsci.2018.12.004_bib0155","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1152\/japplphysiol.00366.2004","article-title":"Mechanisms of vasoactive intestinal peptide-mediated vasodilation in human skin","volume":"97","author":"Wilkins","year":"2004","journal-title":"J. Appl. Physiol. (Bethesda, Md : 1985)"},{"issue":"March (4)","key":"10.1016\/j.jdermsci.2018.12.004_bib0160","article-title":"A study and review of effects of botulinum toxins on mast cell dependent and independent pruritus","volume":"10","author":"Ramachandran","year":"2018","journal-title":"Toxins."},{"issue":"December (3)","key":"10.1016\/j.jdermsci.2018.12.004_bib0165","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.bcp.2015.09.023","article-title":"Inhibition of botulinum neurotoxins interchain disulfide bond reduction prevents the peripheral neuroparalysis of botulism","volume":"98","author":"Zanetti","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"April (2)","key":"10.1016\/j.jdermsci.2018.12.004_bib0170","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"Schiavo","year":"2000","journal-title":"Physiol. Rev."},{"issue":"January (1)","key":"10.1016\/j.jdermsci.2018.12.004_bib0175","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4049\/jimmunol.1101703","article-title":"Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides","volume":"188","author":"Wang","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2018.12.004_bib0180","first-page":"105","article-title":"Growth of human mast cells from bone marrow and peripheral blood-derived CD34+ pluripotent progenitor cells","volume":"315","author":"Kirshenbaum","year":"2006","journal-title":"Methods Mol. Biol."},{"issue":"February (2)","key":"10.1016\/j.jdermsci.2018.12.004_bib0185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2144\/05382RR05","article-title":"Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction","volume":"38","author":"Luu-The","year":"2005","journal-title":"Biotechniques."},{"issue":"October (5)","key":"10.1016\/j.jdermsci.2018.12.004_bib0190","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s12264-018-0230-x","article-title":"Mutant huntingtin causes a selective decrease in the expression of synaptic vesicle protein 2C","volume":"34","author":"Peng","year":"2018","journal-title":"Neurosci. Bull."},{"issue":"March (3)","key":"10.1016\/j.jdermsci.2018.12.004_bib0195","first-page":"434","article-title":"Modulation of chymase-mediated rat serosal mast cell degranulation by trypsin or diisopropyl fluorophosphate","volume":"66","author":"Schick","year":"1989","journal-title":"Immunology"},{"issue":"August (3)","key":"10.1016\/j.jdermsci.2018.12.004_bib0200","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2008.05.050","article-title":"Phosphorylation of SNAP-23 by IkappaB kinase 2 regulates mast cell degranulation","volume":"134","author":"Suzuki","year":"2008","journal-title":"Cell"},{"issue":"October (4)","key":"10.1016\/j.jdermsci.2018.12.004_bib0205","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.4049\/jimmunol.123.4.1445","article-title":"Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells","volume":"123","author":"Schwartz","year":"1979","journal-title":"J. Immunol. (Baltimore, Md : 1950)"},{"issue":"January (1)","key":"10.1016\/j.jdermsci.2018.12.004_bib0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1476-5381.1970.tb10354.x","article-title":"Mechanisms of histamine release by compound 48-80","volume":"38","author":"Rothschild","year":"1970","journal-title":"Br. J. Pharmacol."},{"issue":"May (3204)","key":"10.1016\/j.jdermsci.2018.12.004_bib0215","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1126\/science.123.3204.941","article-title":"Simple procedure for identification and rapid counting of mast cells in tissue sections","volume":"123","author":"Smith","year":"1956","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jdermsci.2018.12.004_bib0220","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1109\/T-UFFC.1986.26814","article-title":"Induction of mast cell degranulation in skin by ultrasound","volume":"33","author":"Dyson","year":"1986","journal-title":"IEEE Trans. Ultrason. Ferroelectr. Freq. Control"},{"issue":"April (5773)","key":"10.1016\/j.jdermsci.2018.12.004_bib0225","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jdermsci.2018.12.004_bib0230","series-title":"Botox [product insert]","year":"2017"},{"key":"10.1016\/j.jdermsci.2018.12.004_bib0235","series-title":"Botox Cosmetic [product insert]","year":"2017"},{"issue":"June (4)","key":"10.1016\/j.jdermsci.2018.12.004_bib0240","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.burns.2012.07.031","article-title":"The effects of botulinum toxin A on mast cell activity: preliminary results","volume":"39","author":"Park","year":"2013","journal-title":"Burns"},{"issue":"April","key":"10.1016\/j.jdermsci.2018.12.004_bib0245","first-page":"24","article-title":"Protective effect of botulinum toxin type a against atopic dermatitis-like skin lesions in NC\/Nga mice","author":"Han","year":"2017","journal-title":"Dermatol. Surg."},{"issue":"April (4)","key":"10.1016\/j.jdermsci.2018.12.004_bib0250","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/jid.2011.424","article-title":"Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea","volume":"132","author":"Sulk","year":"2012","journal-title":"J. Invest. Dermatol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181118304547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181118304547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T10:20:23Z","timestamp":1694514023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181118304547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0923181118304547"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2018.12.004","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum toxin blocks mast cells and prevents rosacea like inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2018.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}